Afton Vechery
Afton Vechery is the co-founder of Modern Fertility and served as its CEO. Modern Fertility is a reproductive health company focused on making personalized fertility information more accessible. The company created a category for proactive fertility providing at-home tests and digital tools for women earlier in life, available online and at major retailers. For its first flagship product, Modern Fertility validated that blood tests done in an infertility clinic could be done from home and published its findings in ACOG鈥檚 Green Journal. The company built a digital experience that allowed customers to understand their fertility hormones, built one of the leading digital communities for people with ovaries and expanded their product portfolio to serve women across their reproductive careers. Modern Fertility continues to publish in top tier journals and develop fertility diagnostics utilizing its largest consented database of fertile women. Prior to Modern Fertility, Afton led strategy and operations at various healthtech startups and most recently led consumer product at 23andMe. Afton has been named to Fortune鈥檚 40 Under 40 list, Inc.鈥檚 Female Founders of 2022 list, Inc.鈥檚 30 Under 30 list and Forbes鈥� 30 Under 30 list. Modern Fertility was named Fast Company鈥檚 #1 Most Innovative Healthcare Company in the world and one of CNBC鈥檚 Most Promising Startups to Watch.
In 2021, Afton sold Modern Fertility to Ro for $225 million, where she joined as President of Women鈥檚 Health. In 2022, Afton transitioned from an operating to advisory role at Ro and is now investing and advising start-ups before she starts her next venture.
Afton is an alumnus of the Science Talent Search 2007 and International Science and Engineering Fair 2005. Her first company stemmed from her 2005 ISEF project, which started her entrepreneurial journey.
She joined the Society鈥檚 Board of Trustees in 2022.